Company Clementia Pharmaceuticals Inc
Equities
CA1855751071
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
James M. Roach
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Jeffrey Packman
PRN | Corporate Officer/Principal | 57 | 13-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert A. Heft
BRD | Director/Board Member | 69 | 13-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,059,166 | 35,900,307 ( 94.33 %) | 0 | 94.33 % |
Company contact information
Clementia Pharmaceuticals, Inc.
1000 de la Gauchetière O bureau 1200
H3B 4W5, Montréal
+
https://www.ipsen.com/Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |